Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine > News > The prevalence of vaping among cancer survivors is worrying
  • News

The prevalence of vaping among cancer survivors is worrying

  • 20 April 2020
  • Elena Riboldi
The prevalence of vaping among cancer survivors is worrying
Total
0
Shares
0
0
0
0
0

The use of electronic cigarettes, or vaping, seems to be particularly common among young cancer survivors: according to a survey on a sample of nearly 1,500 young adult (YA) cancer survivors, just published as a research letter in JAMA Oncology, almost half have ever used e-cigarettes and more than one quarter are current users. Notably, these rates are higher than those recorded among peers without a history of cancer. The high prevalence of vaping in YA cancer survivors suggests that this population may require targeted interventions to quit a habit that is considered dangerous for health.

“Young adults with a history of cancer have previously been shown to engage in high-risk health behaviours more often than their healthy peers despite greater health risks and their susceptibility to late effects of treatment after cancer” explains Helen Parsons, associate professor at School of Public Health of the University of Minnesota and first author of the letter. “However, prior research has not evaluated e-cigarette use among YA cancer survivors relative to their peers without cancer.” The study was performed using data from the 2018 Behavioral Risk Factor Surveillance System (BRFSS). In 2018, this annual telephone survey about health-related topics involved nearly 55,000 US citizens aged 18 to 39 years, 2,1% of whom had a history of cancer.

The proportion of individuals who reported having ever used e-cigarettes was higher among YA cancer survivors than among their peers without a cancer history (46.7% vs 39.1%), so was the proportion of current e-cigarette users (31.3% vs 26.9%). The odds ratio indicated a significant association between cancer history and any use and current use of e-cigarettes. This was true across nearly all demographic subgroups. In adjusted logistic regression analyses, young adults who were non-Hispanic white, younger, male, and living in urban areas were more likely to have ever tried or currently use e-cigarettes. Among cancer survivors, young adults living in urban areas were more likely to have experienced vaping and those who were younger and male were more likely to continue e-cigarette use.

“We found disproportionally higher rates of vaping among YA cancer survivors across nearly all demographic subgroups” the authors conclude. “These results suggest that current efforts to reduce vaping may benefit from targeted interventions among YA cancer survivors”.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • cancer survivors
  • electronic cigarette
  • vaping
  • young adults
Elena Riboldi

Previous Article
  • News

What we know, and ignore, of pediatric palliative care

  • 14 April 2020
  • Alessia De Chiara
View Post
Next Article
  • Articles
  • Practice Points

Covid-19 pandemic: information and resources to support the cancer care community

  • 24 April 2020
  • Cristina Ferrario
View Post
You May Also Like
View Post
  • Articles
  • News

CancerWorld issue #103 (May, 2025)

  • Yeva Margaryan
  • 11 May 2025
View Post
  • News

Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study

  • Janet Fricker
  • 8 May 2025
View Post
  • News
  • Senza categoria

What Caught Our Eye in April: Oncology’s Top Moments

  • Janet Fricker
  • 7 May 2025
View Post
  • News

CancerWorld #102 (April 2025)

  • Yeva Margaryan
  • 22 April 2025
View Post
  • News
  • Senza categoria

What Caught Our Eye in March: Oncology’s Top Moments

  • Janet Fricker
  • 8 April 2025
View Post
  • News

Ovarian cancer: mechanism conferring resistance to immunotherapy revealed

  • Janet Fricker
  • 21 March 2025
View Post
  • News

Muscular strength and cardiorespiratory fitness improve survival in cancer patients

  • Janet Fricker
  • 20 March 2025
View Post
  • News

CancerWorld #101 (February 2025): The Must-Read Oncology Issue Returns to Print with Exclusive Interviews and Breakthroughs

  • Yeva Margaryan
  • 18 March 2025
search
CancerWorld #101 Download CancerWorld #101 Download CancerWorld #101 Download or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • CancerWorld issue #103 (May, 2025)
    • 11 May 2025
  • Personalised neoantigen vaccine for kidney cancer shows promise in phase 1 study
    • 8 May 2025
  • What Caught Our Eye in April: Oncology’s Top Moments
    • 7 May 2025
  • CancerWorld #102 (April 2025)
    • 22 April 2025
  • What Caught Our Eye in March: Oncology’s Top Moments
    • 8 April 2025
Article
  • A Vision for Cancer Policy in Europe: An Interview with MEP Nikos Papandreou
    • 12 May 2025
  • It’s no longer taboo to suggest that some metastatic breast cancers may be curable
    • 12 May 2025
  • (Re)Thinking Psycho-oncology in a world out of balance: What I learned after a year of interviews
    • 12 May 2025
Social

Would you follow us ?

Contents
  • Adrian Gottschalk: Making a Difference for His Fellow Human Beings
    • 10 May 2025
  • ACT for Children:A Global Initiative to Tackle Inequities in Pediatric Cancer
    • 10 May 2025
  • Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
    • 6 May 2025
MENU
  • About the Magazine
    • About us
    • Editorial Team
    • Events
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
  • ESCO Corner
Cancerworld Magazine
  • About us
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is published by OncoDaily (P53 Inc.) | Mailing Address: 867 Boylston st, 5th floor, Ste 1094 Boston, MA 02116, United States | [email protected]

Archivio Cancerworld

Input your search keywords and press Enter.